35532-08-2

Here, we present a new ultramicroporous Cu2 paddlewheel based MOF. This ultramicroporous MOF has most of the features such as porosity (BET surface area = 945 m2/g), CO2 capacity (3.5 mmol/g at ambient temperature and pressure), CO2/N2 selectivity (sCO2/N2 = 250), and fast CO2 diffusion kinetics (Dc = 2.25 × 10-9 m2/s), comparable to some of the other high-performing ultramicroporous MOFs, with strong binding sites. Typically, such MOFs exhibit strong CO2-framework interactions (evidenced from a heat of adsorption ≥ 38 kJ/mol). However, the MOF explained here, despite having channels lined by the amine and the open-metal sites, possesses only a moderate CO2-framework interaction (HOA = 26 kJ/mol). Using periodic DFT, we have probed this counterintuitive observation.

The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to benzimidazole molecules tha

The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to benzimidazole molecules tha

The present invention provides an efficient and versatile method for the synthesis and screening of combinatorial libraries of benzimidazoles, benzoxazoles, benzothiazoles, and derivatives thereof. In order to expedite the synthesis of large arrays of compounds possessing these core structures, a general methodology for solid phase synthesis of these derivatives is provided. Arrays of benzimidazoles, benzoxazoles, benzothiazoles, and derivatives thereof useful as peptidomimetics and for the identification of agents having antifungal, antiviral, antimicrobial, anticoagulant, and antiulcer activity, or use in the treatment of inflammation, hypertension, cancer, and other conditions can be prepared by this method.